Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
for Advanced Solid Tumors
Drug: Ivonescimab
5 locations incl. Norwich
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07397338·Phase 1, Phase 2·Recruiting